基于“一气周流,四象脾土”理论论治非小细胞肺癌
Treatment of Non-Small-Cell Lung Cancer Based on the Theory of “One Qi Circulating Endlessly, Four Emblems of Spleen-Earth”
摘要: 非小细胞肺癌(NSCLC)是现代肿瘤学治疗的难点,中医药通过整体调节展现独特优势。本文以黄元御“一气周流,四象脾土”理论为核心,探讨NSCLC的病机演变与治疗策略。认为中气衰败、脾土不运为发病根本,导致左路肝木升发不足、右路肺金敛降失常、心火不潜、肾水失藏,最终气滞、痰凝、血瘀、毒结聚于肺络。治疗以培补中气、运转脾土为枢轴,辅以疏木达郁、清金降逆、泻南补北等法,恢复一气周流。结合现代肿瘤微环境、免疫代谢等研究,为中西医整合治疗NSCLC提供理论依据。
Abstract: Non-Small Cell Lung Cancer (NSCLC) remains one of the most challenging malignancies in contemporary oncology. Chinese medicine, by virtue of its holistic regulation, demonstrates unique advantages. Centered on Huang Yuanyu’s doctrine of “One Qi Circulating Endlessly, Four Emblems of Spleen-Earth”, this paper explores the pathodynamic evolution and therapeutic strategies of NSCLC. The authors propose that the fundamental pathogenesis lies in the collapse of central Qi and the failure of spleen-earth to transform and transport. Consequently, the ascending of liver-wood on the left pathway becomes insufficient, the descending of lung-metal on the right pathway is disturbed, heart-fire cannot dive, and kidney-water loses its storage. Eventually, qi stagnation, phlegm congelation, blood stasis and toxin accumulation coalesce in the pulmonary collaterals. The core therapeutic principle is to reinforce central Qi and activate spleen-earth as the pivot, assisted by methods of dredging wood to relieve depression, purging metal to descend counterflow, and “draining the south while tonifying the north”, so as to restore the endless circulation of the One Qi. Integrated with modern insights into the tumor microenvironment, immunity and metabolism, the theory provides a conceptual basis for combined Chinese-Western management of NSCLC.
文章引用:龙依萍, 郭俊鸿, 许芳熙, 常秋云. 基于“一气周流,四象脾土”理论论治非小细胞肺癌[J]. 中医学, 2025, 14(11): 4877-4881. https://doi.org/10.12677/tcm.2025.1411703

参考文献

[1] 张婷, 王子康, 夏悦桐. 基于《四圣心源》“一气周流, 土枢四象”探析脾胃病的病机与诊治[J]. 世界中西医结合杂志, 2025, 20(5): 924-928.
[2] 黄元御. 四圣心源[M]. 北京: 中国中医药出版社, 2009: 1, 2, 3, 17-18, 21, 34, 51-52, 60-61, 129.
[3] 胡雨荷, 臧云彩, 李姗. 整合医学下基于圆运动及一气周流理论论治喉癌[J]. 中医学报, 2025, 40(8): 1680-1686.
[4] 陈晓辉, 杨相振, 李耀洋, 等. 基于“肠道菌群-肿瘤微环境”探讨脾虚对肿瘤形成的影响[J]. 时珍国医国药, 2020, 31(7): 1672-1674.
[5] Bercik, P., Verdu, E.F., Foster, J.A., Macri, J., Potter, M., Huang, X., et al. (2010) Chronic Gastrointestinal Inflammation Induces Anxiety-Like Behavior and Alters Central Nervous System Biochemistry in Mice. Gastroenterology, 139, 2102-2112.e1. [Google Scholar] [CrossRef] [PubMed]
[6] 韩钦芮, 符秀琼, 禹志领, 等. 肿瘤微环境的脾虚本质探讨[J]. 中医杂志, 2014, 55(4): 292-294, 298.
[7] 钟娜, 王会杰, 赵文英, 等. 高表达RNF7增强非小细胞肺癌细胞的PD-1耐药: 基于活化NF-κB通路促进CXCL1表达和髓源性抑制细胞的募集[J]. 南方医科大学学报, 2024, 44(9): 1704-1711.
[8] 余涛, 唐晓玲, 熊墨年. 熊墨年运用“益气清毒”法治疗肿瘤经验探析[J]. 实用中西医结合临床, 2017, 17(1): 83-84.
[9] 程海波, 吴勉华. 周仲瑛教授“癌毒”学术思想探析[J]. 中华中医药杂志, 2010, 25(6): 866-869.
[10] 陈旭, 贾波. 《四圣心源》对仲景“苓桂”配伍的继承与发微[J]. 中华中医药杂志, 2019, 34(12): 5626-5628.
[11] 罗元珍, 罗晓欣, 胡方林. 黄元御一气周流论中的气化思维[J]. 中医药导报, 2025, 31(3): 225-228
[12] 彭子益. 圆运动的古中医学[M]. 李可, 主校. 北京: 中国中医药出版社, 2017.
[13] 曹晓霞, 延学学. 八珍汤联合放化疗治疗宫颈癌的临床效果及对患者免疫功能、癌因性疲乏及毒副反应的影响[J]. 临床医学研究与实践, 2022, 7(12): 138-141.